C12Y 114/11016
Peptide-aspartate beta-dioxygenase , i.e. aspartyl beta-hydroxylase
Official title: Peptide-aspartate beta-dioxygenase (1.14.11.16), i.e. aspartyl (asparaginyl) beta-hydroxylase
C12Y114/11016 (Peptide-aspartate beta-dioxygenase , i.e. aspartyl beta-hydroxylase) appears on 11 US grants and 27 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 27
- Assignees
- 6
- Inventors
- 20
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 6 |
| 2003 | 0 | 1 |
| 2004 | 5 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 4 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 3 | 3 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors27 Oct 2020US 10,813,984 B2Rhode Island Hospital
- Automated medical sample collection, testing, and analysis27 Oct 2020US 10,816,545 B22Pi-Sigma Corp.
- Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase7 Jul 2020US 10,702,591 B2Panacea Pharmaceuticals, Inc.
- Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)29 Aug 2017US 9,744,223 B2Panacea Pharmaceuticals, Inc.
- Diagnosis, prognosis and treatment of malignant neoplasms21 Aug 2025US 2025/0264470 A1Rhode Island Hospital
- Aspartate-beta-hydroxylase Induces Epitope-specific T Cell Responses in Tumors27 May 2021US 2021/0154283 A1Rhode Island Hospital
- Combination therapies for cancer5 Nov 2020US 2020/0345820 A1
- Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)6 Aug 2020US 2020/0246443 A1Panacea Pharmaceuticals, Inc.
- Antibodies against aspartyl (asparaginyl) beta-hydroxylase (aabh) and methods of making and using18 Jun 2020US 2020/0190480 A1Next Pharma Inc.
Most cited
By later US patents
- Diagnosis and treatment of malignant neoplasms7US 6,783,758 B2Rhode Island Hospital · 2004
- Diagnosis and treatment of malignant neoplasms6US 6,797,696 B2Rhode Island Hospital · 2004
- Diagnosis and treatment of malignant neoplasms5US 6,812,206 B2Rhode Island Hospital · 2004
- Automated medical sample collection, testing, and analysis4US 10,816,545 B22Pi-Sigma Corp. · 2020
- Diagnosis and treatment of malignant neoplasms3US 6,815,415 B2Rhode Island Hospital · 2004